Mason Institute supports the development of a new Centre for Biomedicine, Self and Society

The Centre will be based at the University of Edinburgh and supported by the Wellcome Trust

The Mason Institute, an interdisciplinary network based at Edinburgh Law School, is proud to be supporting the development of a new Centre for Biomedicine, Self and Society at the University of Edinburgh. Academics from the College of Arts, Humanities and Social Sciences and the College of Medicine and Veterinary Medicine have been awarded a grant of over £1 million from the Wellcome Trust to develop new interdisciplinary approaches to exploring the issues, challenges and questions raised by biomedicine, biotechnology and health care in today’s society.

The team is led by Sarah Cunningham-Burley, Mason Institute Founding Director Graeme Laurie, and Steve Sturdy with co-investigators Sarah Chan (MI Co-Director and Usher Institute Chancellor’s Fellow), Gill Haddow (STIS) and Martyn Pickersgill and Devi Sridhar (Usher Institute). The University has also contributed to the development of the Centre through the appointment of four new Chancellor’s Fellows: MI Co-Director Agomoni Ganguli-Mitra, Lukas Engelmann (STIS), Ellen Stewart and Ingrid Young (Usher).

Over the next five years, the team will investigate a range of issues across five broad themes: “Beyond the Body”, “Beyond Disease”, “Beyond Global”, “Beyond Legal” and “Beyond Engagement”. These strands, as well as highlighting areas of contemporary importance to biomedicine and society, will allow us to demonstrate how novel interdisciplinary team science approaches can go ‘beyond’ current research to produce new insights and understandings. The Wellcome funding will also support recruitment of six new postdoctoral researchers. We will also be hosting a range of doctoral students to complement the existing team.

Through a programme of scientists and artists in residence, colleagues will work alongside Centre researchers to explore new ways of integrating social science and humanities into the study of biomedicine, as well as new approaches to public and stakeholder engagement.